TDP-43 pathology in sporadic ALS occurs in motor neurons lacking the RNA editing enzyme ADAR2
- PMID: 20372915
- DOI: 10.1007/s00401-010-0678-x
TDP-43 pathology in sporadic ALS occurs in motor neurons lacking the RNA editing enzyme ADAR2
Abstract
Both the appearance of cytoplasmic inclusions containing phosphorylated TAR DNA-binding protein (TDP-43) and inefficient RNA editing at the GluR2 Q/R site are molecular abnormalities observed specifically in motor neurons of patients with sporadic amyotrophic lateral sclerosis (ALS). The purpose of this study is to determine whether a link exists between these two specific molecular changes in ALS spinal motor neurons. We immunohistochemically examined the expression of adenosine deaminase acting on RNA 2 (ADAR2), the enzyme that specifically catalyzes GluR2 Q/R site-editing, and the expression of phosphorylated and non-phosphorylated TDP-43 in the spinal motor neurons of patients with sporadic ALS. We found that all motor neurons were ADAR2-positive in the control cases, whereas more than half of them were ADAR2-negative in the ALS cases. All ADAR2-negative neurons had cytoplasmic inclusions that were immunoreactive to phosphorylated TDP-43, but lacked non-phosphorylated TDP-43 in the nucleus. Our results suggest a molecular link between reduced ADAR2 activity and TDP-43 pathology.
Similar articles
-
The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients.Brain Res. 2014 Oct 10;1584:28-38. doi: 10.1016/j.brainres.2013.12.011. Epub 2013 Dec 16. Brain Res. 2014. PMID: 24355598 Review.
-
The abnormal processing of TDP-43 is not an upstream event of reduced ADAR2 activity in ALS motor neurons.Neurosci Res. 2012 Jun;73(2):153-60. doi: 10.1016/j.neures.2012.02.015. Epub 2012 Mar 10. Neurosci Res. 2012. PMID: 22414730
-
[Molecular link between inefficient GluA2 RNA editing and TDP-43 pathology in ALS motor neurons].Brain Nerve. 2012 May;64(5):549-56. Brain Nerve. 2012. PMID: 22570068 Review. Japanese.
-
Profound downregulation of the RNA editing enzyme ADAR2 in ALS spinal motor neurons.Neurobiol Dis. 2012 Mar;45(3):1121-8. doi: 10.1016/j.nbd.2011.12.033. Epub 2011 Dec 28. Neurobiol Dis. 2012. PMID: 22226999
-
Deficient RNA-editing enzyme ADAR2 in an amyotrophic lateral sclerosis patient with a FUS(P525L) mutation.J Clin Neurosci. 2016 Oct;32:128-9. doi: 10.1016/j.jocn.2015.12.039. Epub 2016 Jun 21. J Clin Neurosci. 2016. PMID: 27343041
Cited by
-
Aberrant RNA homeostasis in amyotrophic lateral sclerosis: potential for new therapeutic targets?Neurodegener Dis Manag. 2014;4(6):417-37. doi: 10.2217/nmt.14.36. Neurodegener Dis Manag. 2014. PMID: 25531686 Free PMC article.
-
Rescue of amyotrophic lateral sclerosis phenotype in a mouse model by intravenous AAV9-ADAR2 delivery to motor neurons.EMBO Mol Med. 2013 Nov;5(11):1710-9. doi: 10.1002/emmm.201302935. Epub 2013 Sep 24. EMBO Mol Med. 2013. PMID: 24115583 Free PMC article.
-
Calcium Permeable-AMPA Receptors and Excitotoxicity in Neurological Disorders.Front Neural Circuits. 2021 Aug 17;15:711564. doi: 10.3389/fncir.2021.711564. eCollection 2021. Front Neural Circuits. 2021. PMID: 34483848 Free PMC article. Review.
-
Adenosine-to-inosine RNA editing in neurological development and disease.RNA Biol. 2021 Jul;18(7):999-1013. doi: 10.1080/15476286.2020.1867797. Epub 2021 Jan 6. RNA Biol. 2021. PMID: 33393416 Free PMC article. Review.
-
Viral N protein hijacks deaminase-containing RNA granules to enhance SARS-CoV-2 mutagenesis.EMBO J. 2024 Dec;43(24):6444-6468. doi: 10.1038/s44318-024-00314-y. Epub 2024 Nov 20. EMBO J. 2024. PMID: 39567830 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous